Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|September 12, 2013
Shiga toxin producing E coli bloodstream infection secondary to Strongyloides penetration through intestinal mucosaSancta St Cyr, Avish Nagpal, Muhammad Rizwan Sohail
MMWR. Morbidity and Mortality Weekly Report|December 17, 2020
Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020Sancta St Cyr, Lindley Barbee, Kimberly A Workowski, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2019
Emergence of Neisseria gonorrhoeae Strains Harboring a Novel Combination of Azithromycin-Attenuating MutationsCau D Pham, Samera Sharpe, Karen Schlanger, et al.
Genome Biology and Evolution|December 28, 2021
Global Emergence and Dissemination of Neisseria gonorrhoeae ST-9363 Isolates with Reduced Susceptibility to AzithromycinSandeep J Joseph, Jesse C Thomas, Matthew W Schmerer, et al.
The Lancet. Microbe|October 2, 2020
Azithromycin susceptibility of Neisseria gonorrhoeae in the USA in 2017: a genomic analysis of surveillance dataKim M Gernert, Sandra Seby, Matthew W Schmerer, et al.
Sexually Transmitted Diseases|August 26, 2021
Test of Cure Return Rate and Test Positivity, Strengthening the US Response to Resistant Gonorrhea, United States, 2018-2019Karen Schlanger, Kerry Mauk, Emily R Learner, et al.
Mbio|November 29, 2018
Mechanistic Basis for Decreased Antimicrobial Susceptibility in a Clinical Isolate of Neisseria gonorrhoeae Possessing a Mosaic-Like mtr Efflux Pump LocusCorinne E Rouquette-Loughlin, Jennifer L Reimche, Jacqueline T Balthazar, et al.
The Journal of Infectious Diseases|February 22, 2019
Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016Jesse C Thomas, Sandra Seby, A Jeanine Abrams, et al.
Sexually Transmitted Diseases|August 26, 2021
Demographic and Epidemiological Characteristics Associated With Reduced Antimicrobial Susceptibility to Neisseria gonorrhoeae in the United States, Strengthening the US Response to Resistant Gonorrhea, 2018 to 2019Karen E Gieseker, Emily R Learner, Kerry Mauk, et al.
Pageof 1